Atlantic Trust Group LLC Increases Stake in UnitedHealth Group Inc (UNH)

Atlantic Trust Group LLC grew its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,006,125 shares of the healthcare conglomerate’s stock after purchasing an additional 23,881 shares during the period. UnitedHealth Group makes up 0.9% of Atlantic Trust Group LLC’s investment portfolio, making the stock its 19th biggest holding. Atlantic Trust Group LLC’s holdings in UnitedHealth Group were worth $215,309,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Nicholas Hoffman & Company LLC. raised its holdings in shares of UnitedHealth Group by 10.5% in the 1st quarter. Nicholas Hoffman & Company LLC. now owns 2,317 shares of the healthcare conglomerate’s stock worth $496,000 after acquiring an additional 221 shares during the last quarter. Peapack Gladstone Financial Corp raised its holdings in shares of UnitedHealth Group by 5.0% in the 1st quarter. Peapack Gladstone Financial Corp now owns 4,728 shares of the healthcare conglomerate’s stock worth $1,012,000 after acquiring an additional 224 shares during the last quarter. Almanack Investment Partners LLC. grew its position in UnitedHealth Group by 35.1% in the 4th quarter. Almanack Investment Partners LLC. now owns 870 shares of the healthcare conglomerate’s stock worth $192,000 after purchasing an additional 226 shares in the last quarter. Budros Ruhlin & Roe Inc. grew its position in UnitedHealth Group by 11.1% in the 4th quarter. Budros Ruhlin & Roe Inc. now owns 2,277 shares of the healthcare conglomerate’s stock worth $502,000 after purchasing an additional 228 shares in the last quarter. Finally, CWA Asset Management Group LLC grew its position in UnitedHealth Group by 7.2% in the 4th quarter. CWA Asset Management Group LLC now owns 3,419 shares of the healthcare conglomerate’s stock worth $754,000 after purchasing an additional 230 shares in the last quarter. Hedge funds and other institutional investors own 84.94% of the company’s stock.

A number of brokerages have issued reports on UNH. BMO Capital Markets upped their price objective on shares of UnitedHealth Group from $285.00 to $300.00 and gave the stock a “positive” rating in a research report on Thursday, June 21st. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 19th. SunTrust Banks began coverage on shares of UnitedHealth Group in a research report on Monday, June 11th. They issued a “buy” rating and a $300.00 price objective for the company. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $270.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 18th. Finally, Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $260.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 18th. One analyst has rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $263.00.

In related news, insider Larry C. Renfro sold 19,652 shares of the firm’s stock in a transaction that occurred on Friday, June 15th. The shares were sold at an average price of $254.55, for a total value of $5,002,416.60. Following the completion of the transaction, the insider now directly owns 153,679 shares of the company’s stock, valued at approximately $39,118,989.45. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, April 23rd. The stock was sold at an average price of $234.20, for a total transaction of $3,513,000.00. Following the completion of the transaction, the director now directly owns 1,761,533 shares of the company’s stock, valued at $412,551,028.60. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 49,854 shares of company stock valued at $12,295,675. 0.87% of the stock is owned by insiders.

UnitedHealth Group stock opened at $245.34 on Friday. UnitedHealth Group Inc has a twelve month low of $183.86 and a twelve month high of $256.73. The company has a market cap of $235.34 billion, a PE ratio of 24.36, a P/E/G ratio of 1.41 and a beta of 0.74. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.56.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The firm had revenue of $55.19 billion during the quarter, compared to the consensus estimate of $54.90 billion. During the same period in the prior year, the firm earned $2.37 EPS. The company’s revenue was up 13.3% compared to the same quarter last year. equities analysts expect that UnitedHealth Group Inc will post 12.62 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 26th. Investors of record on Monday, June 18th were issued a $0.90 dividend. The ex-dividend date was Friday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.75. This represents a $3.60 annualized dividend and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.75%.

UnitedHealth Group declared that its board has approved a stock buyback program on Wednesday, June 6th that allows the company to repurchase 100,000,000 shares. This repurchase authorization allows the healthcare conglomerate to purchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply